Enovis Corporation
$26.27
▼
-3.12%
2026-04-21 06:39:00
www.enovis.com
NYQ: ENOV
Explore Enovis Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.52 B
Current Price
$26.27
52W High / Low
$37.85 / $21
Stock P/E
—
Book Value
$26.05
Dividend Yield
—
ROCE
-0.58%
ROE
-58.27%
Face Value
—
EPS
$-20.72
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
7,802
Beta
1.59
Debt / Equity
92.47
Current Ratio
2.02
Quick Ratio
1.04
Forward P/E
6.16
Price / Sales
0.63
Enterprise Value
$2.74 B
EV / EBITDA
7.43
EV / Revenue
1.22
Rating
Strong Buy
Target Price
$45.09
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AdaptHealth Corp. | $12.67 | — | $1.72 B | — | 5.17% | -4.25% | $12.87 / $7.11 | $11.46 |
| 2. | Haemonetics Corporation | $61.17 | 16.14 | $2.83 B | — | 10.74% | 19.3% | $87.32 / $47.31 | $19.46 |
| 3. | Apyx Medical Corporation | $3.94 | — | $166.48 M | — | -11.69% | -76.15% | $4.5 / $0.83 | $0.35 |
| 4. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 5. | TELA Bio, Inc. | $0.63 | — | $30.55 M | — | -53.21% | -2.23% | $2.2 / $0.5 | $0.14 |
| 6. | Inspire Medical Systems, Inc. | $56.97 | 11.28 | $1.64 B | — | 6.28% | 19.77% | $163.35 / $48.3 | $27.33 |
| 7. | Medtronic plc | $83.14 | 23.25 | $107.11 B | 3.34% | 8.3% | 9.39% | $106.33 / $79.93 | $38.17 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 575.76 M | 548.91 M | 564.54 M | 558.83 M | 560.98 M |
| Operating Profit | 48.25 M | -8.14 M | -16.08 M | -42.91 M | -15.02 M |
| Net Profit | -520.59 M | -571.15 M | -36.74 M | -55.97 M | -703.34 M |
| EPS in Rs | -9.05 | -9.93 | -0.64 | -0.97 | -12.22 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.25 B | 2.11 B | 1.71 B | 1.56 B |
| Operating Profit | -18.87 M | -103.43 M | -48.37 M | -90.66 M |
| Net Profit | -1.18 B | -825.49 M | -33.26 M | -13.29 M |
| EPS in Rs | -20.58 | -14.35 | -0.58 | -0.23 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.83 B | 4.72 B | 4.51 B | 4.27 B |
| Total Liabilities | 2.34 B | 2.15 B | 1.09 B | 823.45 M |
| Equity | 1.49 B | 2.56 B | 3.42 B | 3.45 B |
| Current Assets | 1.21 B | 1.15 B | 896.52 M | 795.02 M |
| Current Liabilities | 598.47 M | 529 M | 369.61 M | 565.2 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 217.29 M | 113.5 M | 134.99 M | -55.86 M |
| Investing CF | -179.37 M | -955.47 M | -242.47 M | -176.39 M |
| Financing CF | -52.4 M | 846.82 M | 127.8 M | -465.13 M |
| Free CF | 19.92 M | -67.21 M | 12.77 M | -161.31 M |
| Capex | -197.38 M | -180.71 M | -122.22 M | -105.45 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 23.46% | 9.22% | — | — |
| Earnings Growth % | -2381.87% | -150.23% | — | — |
| Profit Margin % | -39.17% | -1.95% | -0.85% | — |
| Operating Margin % | -4.91% | -2.83% | -5.8% | — |
| Gross Margin % | 56.02% | 58.04% | 55.62% | — |
| EBITDA Margin % | -22.82% | 9.94% | 15.46% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2022-04-05 | 1:0.581 |